FDA Adverse Event Malfunction Summary report: N

BOTTLE TB AURAMINE M 250ML

MDR report key: 12558067 · Received September 30, 2021

Report

Report Number
1119779-2021-01599
Event Type
Malfunction
Date Received
September 30, 2021
Date of Event
August 31, 2021
Report Date
November 8, 2021
Manufacturer
BECTON, DICKINSON & CO. (SPARKS)
Product Code
KJK
UDI-DI
00382902125143
PMA / PMN Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS WERE UPDATED DUE TO ADDITIONAL INFORMATION: D10: DEVICE AVAILABLE FOR EVAL YES. D10: RETURNED TO MANUFACTURER ON: 2021-09-20. H6: INVESTIGATION SUMMARY THE FOLLOWING SUMMARY IS IN RESPONSE AGAINST MATERIAL 212514, AND LOT 0288107 FOR PRECIPITATE DEFECTS. COMPONENTS ARE MIXED AND DISPENSED INTO THE APPROPRIATE CONTAINERS. AFTER QC TESTING PRODUCT IS RELEASED AND TRANSPORTED TO THE DISTRIBUTION CENTER. THE COMPLAINT INVESTIGATION INCLUDED A REVIEW OF THE BATCH HISTORY RECORD TB AURAMINE M. THE BATCH HISTORY RECORD REVIEW INDICATED NO DISCREPANCIES. ALL RELEASE TESTING WAS SATISFACTORY. SATISFACTORY APPEARANCE PER THE BD COA IS ¿YELLOW SUSPENSION¿. BY DEFINITION A SUSPENSION IS ¿A MIXTURE IN WHICH PARTICLES ARE DISPERSED THROUGHOUT THE BULK OF THE FLUID¿. IT IS ALSO DEFINED AS ¿A MIXTURE IN WHICH ALL PARTICLES OF A SUBSTANCE ARE DISPERSED THROUGHOUT A GAS OR LIQUID. IF A SUSPENSION IS LEFT UNDISTURBED, THE PARTICLES ARE LIKELY TO SETTLE TO THE BOTTOM. THE PARTICLES IN A SUSPENSION ARE LARGER THAN THOSE IN EITHER A COLLOID OR A SOLUTION¿. COMPLAINT TRENDS WERE REVIEWED FOR A PERIOD COVERING 12 MONTHS. DURING THAT TIME THERE HAVE BEEN NO CONFIRMED COMPLAINTS FOR THE DEFECT IN QUESTION FOR THIS PRODUCT. THE RETURN RECEIVED ON 09/20/21. THE RETURN BOTTLE WAS PREVIOUSLY OPENED AND ALMOST EMPTY. THE RETURN AND RETENTION SAMPLES FROM THE COMPLAINT BATCH WERE EVALUATED ALONG WITH A CONTROL BATCH OF TB AURAMINE M. THERE WAS A LARGE AMOUNT OF PARTICULATE VISIBLE IN THE RETURN AND RETENTION SAMPLES AS WELL AS THE CONTROL. STAINING WAS COMPLETED PER INSTRUCTIONS IN THE PRODUCT INSERT. SLIDES OF POSITIVE (M. TUBERCULOSIS ATCC 25177) AND NEGATIVE (B. SUBTILIS ATCC 6533) CONTROLS WERE EVALUATED AND GAVE SATISFACTORY STAINING RESULTS WITH THE RETURN, RETENTION AND CONTROL BATCHES. THE RETURN AND RETENTION SAMPLES WERE COMPARABLE TO THE CONTROL. THE PRESENCE OF THE PARTICLES IS NOT CONSIDERED A PRODUCT DEFECT FOR TB AURAMINE, AS THEY ARE EXPECTED TO BE PRESENT WITHIN THE SUSPENSION, AND ALLOWABLE PER CLAIMS ON THIS PRODUCT. CONSEQUENTLY, THIS COMPLAINT CANNOT BE CONFIRMED. H3 OTHER TEXT : SEE H10.

Additional Manufacturer Narrative · 0

A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE BOTTLE TB AURAMINE M 250ML EXPERIENCED BIOLOGICAL CONTAMINATION. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CUSTOMER REPORTED SEDIMENTS/PRECIPITATES IN THEIR BOTTLE OF TB AURAMINE M STAIN FROM LOT 0288107, EXP: 2021-10-31 (CAT# 212514). THEY ARE USING THE TB FLUORESCENT STAIN KIT M FOR THE MORSE COLORATION. SHE DIDN¿T PROVIDE THE STAIN KIT LOT NUMBER.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE BOTTLE TB AURAMINE M 250ML EXPERIENCED BIOLOGICAL CONTAMINATION. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CUSTOMER REPORTED SEDIMENTS/PRECIPITATES IN THEIR BOTTLE OF TB AURAMINE M STAIN FROM LOT 0288107, EXP: 2021-10-31 (CAT# 212514). THEY ARE USING THE TB FLUORESCENT STAIN KIT M FOR THE MORSE COLORATION. SHE DIDN¿T PROVIDE THE STAIN KIT LOT NUMBER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1449576 BOTTLE TB AURAMINE M 250ML SYSTEM, BLOOD CULTURING KJK BECTON, DICKINSON & CO. (SPARKS) 212514 0288107 00382902125143

Patients

Seq Age Sex Outcome Treatment
1 Unknown